|
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
|
30285260 |
2019 |
|
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of schizophrenia in Ashkenazi Jews.
|
26198764 |
2015 |
|
Bipolar Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.
|
20351715 |
2011 |
|
Major Depressive Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.
|
20351715 |
2011 |
|
Major Depressive Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.
|
20351715 |
2011 |
|
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1.
|
30803311 |
2019 |
|
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
MiR-155 directly reduced the expression of the tumor suppressor DMTF1.
|
25965824 |
2015 |
|
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interacts with cyclin D, is a positive regulator of the p14ARF (ARF) tumor suppressor.
|
26187004 |
2015 |
|
Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
DMP1, encoding cyclin D binding myb-like protein 1 was one of the genes specifically affected by Tet-inducible FAK or FAK-CD in breast xenograft tumors.
|
19671193 |
2009 |
|
Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
Further study will be needed to determine whether gene-specific mutations implicate hDMP1 as a tumor suppressor in acute leukemias with deletions of the long arm of chromosome 7 or in other types of human malignancy.
|
10095122 |
1999 |
|
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
c-MYB and DMTF1 in Cancer.
|
30599775 |
2019 |
|
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
c-MYB and DMTF1 in Cancer.
|
30599775 |
2019 |
|
Malignant Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Further study will be needed to determine whether gene-specific mutations implicate hDMP1 as a tumor suppressor in acute leukemias with deletions of the long arm of chromosome 7 or in other types of human malignancy.
|
10095122 |
1999 |
|
Primary malignant neoplasm
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Further study will be needed to determine whether gene-specific mutations implicate hDMP1 as a tumor suppressor in acute leukemias with deletions of the long arm of chromosome 7 or in other types of human malignancy.
|
10095122 |
1999 |
|
Dentin Sensitivity
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therefore, DMP-1@MTA@AHBMM can be a promising method for the management of DH.
|
31497837 |
2019 |
|
Diabetic Nephropathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
DMP-1 attenuates oxidative stress and inhibits TGF-β activation in rats with diabetic kidney disease.
|
27876428 |
2017 |
|
Malignant neoplasm of urinary bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
The identification of miR-155 and its novel target DMTF1 will be valuable in developing diagnostic markers and therapeutic applications for bladder cancer.
|
25965824 |
2015 |
|
Bladder Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
The identification of miR-155 and its novel target DMTF1 will be valuable in developing diagnostic markers and therapeutic applications for bladder cancer.
|
25965824 |
2015 |
|
Kidney Failure, Acute
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interacts with cyclin D, is a positive regulator of the p14ARF (ARF) tumor suppressor.
|
26187004 |
2015 |
|
Acute Promyelocytic Leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Treatment of acute promyelocytic leukemia patient samples with all-trans retinoic acid promoted differentiation to granulocytes and restored DMP1 transcripts to normal granulocyte levels.
|
26187004 |
2015 |
|
Rheumatic Fever
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interacts with cyclin D, is a positive regulator of the p14ARF (ARF) tumor suppressor.
|
26187004 |
2015 |
|
Acute respiratory failure
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The human DMTF1 (DMP1) transcription factor, a DNA binding protein that interacts with cyclin D, is a positive regulator of the p14ARF (ARF) tumor suppressor.
|
26187004 |
2015 |
|
Carcinoma of bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
The identification of miR-155 and its novel target DMTF1 will be valuable in developing diagnostic markers and therapeutic applications for bladder cancer.
|
25965824 |
2015 |
|
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, hDMP1 loss could be a novel diagnostic marker for non-small-cell lung carcinomas.
|
18598225 |
2008 |
|
Carcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Loss of heterozygosity (LOH) of the hDMP1 gene was detectable in approximately 35% of human lung carcinomas, which was found in mutually exclusive fashion with LOH of INK4a/ARF or that of P53.
|
17936562 |
2007 |